Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T12:20:19.435Z.
Calculation as of: 2026-10-06T12:20:19.435Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Alamar Biosciences, Inc.
Market Cap
$2.64B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.64B
Operating Cash Flow Yield
N/A
TTM Avg
3.96%
3Y Avg
3.96%
5Y Avg
3.96%
Market Cap
$2.69B
Operating Cash Flow Yield
7.83%
TTM Avg
13.68%
3Y Avg
9.67%
5Y Avg
8.30%
Market Cap
$2.69B
Operating Cash Flow Yield
6.24%
TTM Avg
6.21%
3Y Avg
4.04%
5Y Avg
3.58%
Market Cap
$2.51B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Operating Cash Flow Yield
3.18%
TTM Avg
2.78%
3Y Avg
2.88%
5Y Avg
3.12%
Market Cap
$2.87B
Operating Cash Flow Yield
2.26%
TTM Avg
3.24%
3Y Avg
1.81%
5Y Avg
1.81%
Market Cap
$2.87B
Operating Cash Flow Yield
5.09%
TTM Avg
4.84%
3Y Avg
2.97%
5Y Avg
2.97%
Market Cap
$2.88B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.64B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | N/A | 3.96% | 3.96% | 3.96% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 7.83% | 13.68% | 9.67% | 8.30% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 6.24% | 6.21% | 4.04% | 3.58% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 3.18% | 2.78% | 2.88% | 3.12% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 2.26% | 3.24% | 1.81% | 1.81% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 5.09% | 4.84% | 2.97% | 2.97% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 5.83% | 3.59% | 2.39% | 2.39% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
